Products

What will AGI do for Atenolol hydrochloride?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H22N2O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6DI0UT7U1Q, chemically known as benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, monohydrochloride but more generally known as atenolol hydrochloride, which bears US NIH Compound Identifier 119274. European Medicines Agency schedules Atenolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00615MIG. Most nations, for tariff and trade purposes, schedule atenolol hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, ATENOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)NCC(COC1CCC(CC1)CC(=O)N)O.CL.

How AGI delivers it

Four ways AGI delivers for Atenolol hydrochloride

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Atenolol hydrochloride, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Atenolol hydrochloride, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Atenolol hydrochloride connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Particle Size Distributionmodel